#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16296	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2152	752.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1430	1430	C	966	C	914	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16296	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2152	752.5	0	HET	.	.	.	G478A	.	478	478	G	724	724	G	1021	G,A	779,179	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29460	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	796.5	0	.	n	.	0	T695C	SNP	695	695	T	1124	1124	C	872	C,T	819,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29460	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	796.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1766	1766	A	1033	A,G	966,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29460	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	796.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2400	2400	C	938	C	880	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29460	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	796.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2474	2474	A	940	A	897	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29460	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3689	796.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3026	3026	C	912	C	853	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2028	folP	855	855	100.0	folP.l6.c30.ctg.1	1664	121.5	1	SNP	p	R229S	0	.	.	685	687	CGC	1056	1058	CGC	207;204;206	C;G;C	189;189;189	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4720	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3422	137.4	1	SNP	p	S91F	0	.	.	271	273	TCC	616	618	TCC	158;157;160	T;C;C	145;147;147	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4720	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3422	137.4	1	SNP	p	D95G	0	.	.	283	285	GAC	628	630	GAC	160;158;157	G;A;C	150;146;147	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4720	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3422	137.4	1	SNP	p	D95N	0	.	.	283	285	GAC	628	630	GAC	160;158;157	G;A;C	150;146;147	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1576	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1417	111.0	1	SNP	p	G45D	1	.	.	133	135	GAC	444	446	GAC	188;186;189	G;A;C	179;174;181	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	832	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1115	74.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5200	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3017	171.7	1	SNP	p	D86N	0	.	.	256	258	GAC	562	564	GAC	205;206;206	G;A;C,G	198;197;199,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5200	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3017	171.7	1	SNP	p	S88P	0	.	.	262	264	TCC	568	570	TCC	209;212;211	T;C;C	195;201;202	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4222	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2581	162.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	221;218;218	G;G;C	203;198;198	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	0	.	p	.	0	F519L	NONSYN	1555	1557	TTT	1963	1965	TTG	203;208;207	T;T;G,T	190;190;187,2	.	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1339	1341	GCA	209;212;210	G;C;A	199;199;203	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1342	1344	ATC	210;209;215	A;T;C	203;200;208	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1354	1356	GTG	211;209;211	G;T;G	204;202;201	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1354	1356	GTG	211;209;211	G;T;G	204;202;201	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1858	1860	ACC	206;205;202	A;C;C	184;186;188	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1912	1914	GCG	183;180;180	G;C;G,A	163;151;157,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1912	1914	GCG	183;180;180	G;C;G,A	163;151;157,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2035	2037	GGC	196;193;193	G,A;G;C	184,1;181;179	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2044	2046	GGC	183;180;179	G;G;C	171;168;167	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	4018	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2454	163.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2062	2064	CTG	171;172;170	C,G;T,C;G	127,6;125,1;128	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5958	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3177	186.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1684	1686	CCG	226;228;229	C;C;G	196;206;201	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2194	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1791	121.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	409	411	GGC	143;144;145	G;G;C	132;135;139	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2194	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1791	121.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	591	591	C	150	C	135	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	436	438	GAA	270;269;263	G,T;A;A	254,1;251;246	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	K120D	NONSYN	358	360	AAG	682	684	GAC	241;236;236	G,A;A;C,G	225,1;217;220,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	G140K	NONSYN	418	420	GGA	742	744	AAA	246;246;247	A;A;A	232;231;233	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	751	753	GAA	247;248;254	G,A;A;A	232,1;235;238	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	883	885	CGA	236;237;234	C;G,A;A	224;218,1;217	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	S189G	NONSYN	565	567	AGC	889	891	GGC	235;232;228	G,A;G,A;C	216,1;215,1;208	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	N212D	NONSYN	634	636	AAT	958	960	GAT	249;248;250	G;A;T	231;229;226	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	D213N	NONSYN	637	639	GAT	961	963	AAT	247;249;250	A;A;T	232;234;233	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	T215S	NONSYN	643	645	ACT	967	969	TCT	247;250;253	T;C;T	229;234;238	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	G255Q	NONSYN	763	765	GGA	1087	1089	CAA	208;208;205	C;A;A	201;202;198	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	.	INDELS	766	768	ACA	1091	1095	ATCAA	203;208;212;211;210	A;T;C;A;A	197;201;206;206;205	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	.	INDELS	769	770	TG	1098	1100	AGT	207;208;209	A;G;T	201;203;202	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	A259D	NONSYN	775	777	GCT	1105	1107	GAT	214;210;210	G;A;T,C	206;199;199,2	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1165	1167	GTA	222;219;222	G;T;A	211;208;213	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1210	1212	GAT	228;226;227	G;A;T	221;219;220	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1219	1221	AAC	228;227;229	A,G;A;C	219,1;217;221	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3020	porB1b	1047	1047	96.87	porB1b.l6.c4.ctg.1	1569	191.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1222	1224	CAC	233;236;236	C,T;A,T;C	223,1;225,1;228	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12160	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5026	241.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1302	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1148	112.8	1	SNP	p	V57M	1	.	.	169	171	ATG	581	583	ATG	252;250;247	A,G;T;G	240,1;239;236	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
